AtaiBeckley stockholders approve Eli Lilly merger; closing expected Sept 11, 2026

AtaiBeckley Inc.

Merger proposal approved: 237,762,253 shares for, 5,033,755 against, 555,549 abstentions.
Adjournment proposal passed (229,411,340 for) but not acted upon since merger approved.
Deal with Eli Lilly via subsidiary Albali Acquisition Corp; merger agreement dated July 15, 2026.
Merger expected to close on September 11, 2026, subject to satisfaction of remaining conditions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.